Abiraterone prostate cancer treatment to be covered by Axa PPP
Change of stance on abiraterone by UK's second largest private medical insurance firm brings it in line with Bupa and WPA A leading insurance company has changed the terms of its private medical cover to ensure policyholders suffering from late-stage prostate cancer can be treated with the drug abiraterone. Axa PPP, the second biggest private medical insurance company in the UK, providing cover ...
Read more...
Cancer patients on abiraterone face cost conundrum
Prostate cancer drug is currently available through the Cancer Drugs Fund, but funding issues mean patients could either have to buy it themselves or take out health insurance Men in England with late-stage prostate cancer could soon be stopped from accessing "breakthrough" drug abiraterone unless they can afford to buy the drug themselves or pay for private medical insurance. Trials of ...
Read more...
PhilHealth seeks changes in medical health care program
THE Philippine Health Insurance Corporation (Philhealth) is seeking changes in its medical health care program to improve services in the next few years. Dr. Eduardo P.
Read more...
Pressure to introduce universal health insurance rises
Health Minister James Reilly will come under increasing pressure to introduce proposals for universal health insurance as more people are priced out of the private health insurance market, a leading patient advocate has warned.
Read more...
Dispute is ended at hospital
THE future of Banbury’s private hospital, the BMI Foscote, is secure following the settlement of a row over treatments covered by medical insurance.
Read more...
|